Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective and Descriptive Analysis of the Regimens of Treatment With FVIII, FIX and By-passing Agents for Hemophiliacs A or B With or Without Inhibitors, From the Existing Registry BERHLINGO, Before and After the Launch of New Entended Half-life Clotting Factors in Seven Haemophilia Treatment Centers in France

NCT03596814 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03596814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03596814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective and Descriptive Analysis of the Regimens of Treatment With FVIII, FIX and By-passing Agents for Hemophiliacs A or B With or Without Inhibitors, From the Existing Registry BERHLINGO, Before and After the Launch of New Entended Half-life Clotting Factors in Seven Haemophilia Treatment Centers in France
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
November 13, 2019
Completion date
December 31, 2019
Enrollment
2,072 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia